I have shares in two accounts. One of those is a
Post# of 155205

Since I am retired and don't need the money in the Roth, I can trade without any tax considerations. I converted to a Roth much later than I should have, but I have since met my 5 year requirement. If CYDY and Leronlimab perform, as we hope they do, the funds could serve as an important windfall for any variety of needs or aspirations.
The other account is taxable, but I intend to donate half of the shares to the church-tax free. The deduction will be helpful to me and the "accrued value" (There isn't much accrued value yet.) will be beneficial to the church. Most of the other shares will be donated similarly to the kids and grandkids. Of course, if we are wrong about Leronlimab, no one benefits. However, I think most everyone here is optimistic about it's future.
Just a couple thoughts I wish someone had shared with me 15 years ago, after my first purchase of CYDY. ABP (average buying price) is about .48. Those sub-.15 purchases look good at this point.

